These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10848688)

  • 1. Rethinking the secondary prevention of superficial bladder cancer: is there a role for retinoids?
    Nutting C; Huddart RA
    BJU Int; 2000 Jun; 85(9):1023-6. PubMed ID: 10848688
    [No Abstract]   [Full Text] [Related]  

  • 2. [Retinoids in recurrence of superficial bladder tumors].
    Tenaglia R; Lucherini A; Rossetti R; Izzi R; Michetti P; Caponera M; Di Silverio F
    Minerva Urol Nefrol; 1988; 40(3):163-6. PubMed ID: 3238541
    [No Abstract]   [Full Text] [Related]  

  • 3. Retinoids in the prevention of bladder cancer.
    Nutting CM; Huddart RA
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):541-5. PubMed ID: 12113086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of superficial bladder cancer.
    Kamat AM
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):799-808. PubMed ID: 14686702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial bladder cancer--problems with selection.
    Glashan RW
    Prog Clin Biol Res; 1985; 185B():13-8. PubMed ID: 4034586
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of bladder cancer chemoprevention].
    Dai G; Wang X
    Wei Sheng Yan Jiu; 2003 Mar; 32(2):159-62. PubMed ID: 12793013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local adriamycin treatment for prevention of recurrence of superficial bladder tumours.
    Kondás J; Szentgyörgyi E; Szöke D
    Int Urol Nephrol; 1988; 20(6):611-5. PubMed ID: 3229933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of recurrent superficial bladder cancer.
    Aso Y
    Curr Urol Rep; 2002 Oct; 3(5):335-6. PubMed ID: 12354339
    [No Abstract]   [Full Text] [Related]  

  • 9. Repeat transurethral resection lowers recurrence rates in T1 bladder tumors, even after intravesical mitomycin C.
    Oosterlinck W
    Nat Clin Pract Urol; 2006 Nov; 3(11):582-3. PubMed ID: 17088923
    [No Abstract]   [Full Text] [Related]  

  • 10. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.
    Veenema RJ; Dean AL; Uson AC; Roberts M; Longo F
    J Urol; 1969 May; 101(5):711-5. PubMed ID: 4976352
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitomycin C therapy in superficial bladder cancer.
    Denis L; Keuppens F; Hendrickx G
    Prog Clin Biol Res; 1985; 185B():113-22. PubMed ID: 3929269
    [No Abstract]   [Full Text] [Related]  

  • 12. [BCG vaccine and prevention of recurrence of superficial cancer of the bladder. Have all the possibilities been exhausted?].
    Vera-Donoso CD; Llopis Minguez B; Gallego Gómez J; Jiménez Cruz JF
    Actas Urol Esp; 1989; 13(4):233-5. PubMed ID: 2678933
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinoids in superficial bladder tumours update.
    Khoury S
    Prog Clin Biol Res; 1984; 162B():347-54. PubMed ID: 6209722
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
    García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; González Alvarez RC; Jalón Monzón A; Martínez Gómez FJ; Sánchez Trilla A; Regadera Sejas J
    Arch Esp Urol; 2007; 60(1):36-43. PubMed ID: 17408170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on "Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer?".
    Naito S
    Nat Clin Pract Urol; 2009 Mar; 6(3):E5. PubMed ID: 19265853
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Adjuvant intravesical thiotepa and bladder tumour recurrence.
    Boyd PJ; Burnand KG
    Br J Surg; 1975 Feb; 62(2):162. PubMed ID: 803851
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of prophylactic Immucothel in patients pretreated with conventional drugs to prevent recurrence of superficial bladder carcinoma.
    Echarti C; Jurincic-Winkler CD; Klippel KF
    Eur Urol; 2000; 37 Suppl 3():50-3. PubMed ID: 10828688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Directed chemotherapy in superficial carcinoma conditioned by the knowledge of relapse factors].
    Oliver F; Llopis B; Vera C; Domínguez C; Vidal J; Gallego J; Jiménez JF
    Actas Urol Esp; 1988; 12(5):419-23. PubMed ID: 3218579
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials.
    Huncharek M; Geschwind JF; Witherspoon B; McGarry R; Adcock D
    J Clin Epidemiol; 2000 Jul; 53(7):676-80. PubMed ID: 10941943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.